C

Carilion Clinic | Research and Development

Research site
(Unclaimed)
Location
101 Elm Avenue SE, 2nd Floor, Roanoke, Virginia, United States of America
Site insights

Top conditions

Ulcer (8 trials)

Crohn Disease (5 trials)

Hypertension (5 trials)

Esophagitis (4 trials)

Ulcerative Colitis (4 trials)

Top treatments

Treprostinil
Upadacitinib
Mirikizumab
CC-93538
Budesonide
Aspirin
DP-b99
Capsaicin
Calcium
PER

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

21 of 80
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

A prospective, open-label, phase 2 study to explore CAIX expression through 89Zirconium-labelled girentuximab deferoxamine (89Zr-girentuximab) PET/CT...

Enrolling
Epithelial Ovarian Cancer
Glioblastoma Multiforme
Drug: 89Zr-DFO-girentuximab

The purpose of this study is to evaluate the efficacy and safety of mirikizumab as maintenance therapy in participants who completed as clinical resp...

Active, not recruiting
Ulcerative Colitis
Drug: Placebo SC
Drug: Mirikizumab SC

Objectives of this study are to determine whether active VNS Therapy treatment is superior to a no stimulation control in producing a reduction in ba...

Enrolling
Treatment Resistant Depression
Device: Vagus Nerve Stimulation (VNS)

The primary objective of this study is to assess the effect of early and rapid treprostinil therapy for mean pulmonary artery pressure (mPAP) reducti...

Enrolling
Pulmonary Arterial Hypertension
Drug: Oral Treprostinil
Drug: Parenteral Treprostinil

The purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe System...

Enrolling
Systemic Lupus Erythematosus
Drug: Deucravacitinib
Other: Placebo

Study CC-93538-EE-001 is a Phase 3, multicenter, multinational, randomized, double-blind, placebo-controlled induction and maintenance study to evalu...

Active, not recruiting
Eosinophilic Esophagitis
Drug: CC-93538
Other: Placebo
Locations recently updated

This study is designed to evaluate the long-term efficacy and safety of mirikizumab in participants with moderately to severely active ulcerative col...

Enrolling
Ulcerative Colitis
Drug: Mirikizumab

This study consists of two periods. The objective of Period 1 is to evaluate the efficacy of upadacitinib in combination with a 26-week corticosteroi...

Active, not recruiting
Giant Cell Arteritis (GCA)
Drug: Upadacitinib
Other: Placebo

The purpose of this study is to test an experimental device, the Adherus AutoSpray and Adherus AutoSpray ET Dural Sealant, in spinal surgical procedu...

Invitation-only
Spinal Duraplasty
Device: DuraSeal Exact Dural Sealant System
Device: Adherus Dural Sealant System

The purpose of this study is to evaluate the safety and efficacy of Mirikizumab in participants with moderately to severely active ulcerative colitis...

Active, not recruiting
Ulcerative Colitis
Drug: Mirikizumab
Drug: Placebo

It is hypothesized that application at 4-week or greater intervals of the human placental umbilical cord tissue TTAX01 to the surface of a well debri...

Active, not recruiting
Diabetic Foot Infection
Non-healing Wound
Biological: TTAX01
Other: Standard Care

To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Repair System in patients with symptomatic severe tricuspid regurgitati...

Enrolling
Tricuspid Valve Insufficiency
Tricuspid Valve Disease
Drug: Optimal Medical Therapy
Device: Edwards PASCAL System

The purpose of this study is to assess if using the Impella® CP (or Impella® 2.5) device during high-risk PCI in patients with reduced left-sided hea...

Enrolling
Coronary Artery Disease
Left Ventricular Dysfunction
Device: Impella CP® / Impella CP® with SmartAssist® / Impella 2.5®
Device: IABP Intra-aortic balloon pump

This study aims to confirm non-inferiority of the BioFreedom™ Drug Coated Stent to the Gazelle™ Bare Metal Stent arm of the Leaders Free study (NCT01...

Active, not recruiting
High Bleeding Risk
Acute Coronary Syndrome
Device: BioFreedom™ Drug Coated Coronary Stent System
Drug: Antiplatelet Drug

Prospective, non-randomized, multi-center clinical investigation of the NEXUS™ Aortic Arch Stent Graft System (NEXUSTM) for the treatment of thoracic...

Enrolling
Intramural Hematoma
Penetrating Aortic Ulcer
Device: NEXUS Aortic Stent Graft System

Systemic Lupus Erythematosus (SLE) is an immune-mediated disease associated with inflammation of multiple organ systems. This study will assess how s...

Enrolling
Systemic Lupus Erythematosus
Drug: Upadacitinib
Drug: Placebo

This trial is intended to study the safety and effectiveness of an new anti-epileptic drug (AED) on Primary Generalized Tonic-Clonic (PGTC) Seizures....

Enrolling
Primary Generalized Epilepsy
Drug: Placebo
Drug: Cenobamate

This is an open label, multi-center trial of tisotumab vedotin monotherapy and in combination with bevacizumab, pembrolizumab, or carboplatin in subj...

Active, not recruiting
Cervical Cancer
Drug: Bevacizumab
Drug: Pembrolizumab

This study is an open-label, uncontrolled study design to evaluate the long-term safety and tolerability of treatment with CC-93538. The study will e...

Enrolling
Eosinophilic Esophagitis
Drug: CC-93538

The purpose of this study is to compare the efficacy and safety of intravenous (IV) infusions of MT-3921 to placebo in subjects with acute traumatic...

Enrolling
Spinal Cord Injury
Biological: Placebo
Biological: MT-3921

Trial sponsors

C

Carilion Clinic (18 trials)

United Therapeutics logo

United Therapeutics (6 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems